123 related articles for article (PubMed ID: 35900536)
1. Expression of glucose transporter 1 (
Vasudevan S; Mehta A; Sharma SK; Sharma A
J Cancer Res Ther; 2022; 18(3):650-655. PubMed ID: 35900536
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis.
Shen YM; Arbman G; Olsson B; Sun XF
Int J Biol Markers; 2011; 26(3):166-72. PubMed ID: 21786248
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas.
Jun YJ; Jang SM; Han HL; Lee KH; Jang KS; Paik SS
World J Gastroenterol; 2011 Apr; 17(14):1866-73. PubMed ID: 21528061
[TBL] [Abstract][Full Text] [Related]
5. Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.
GabAllah GMK; El-Din Habib MS; Soliman SE; Kasemy ZA; Gohar SF
Saudi J Gastroenterol; 2017; 23(6):348-356. PubMed ID: 29205188
[TBL] [Abstract][Full Text] [Related]
6. The Interaction of GLUT1 and FOXM1 Leads to a Poor Prognosis in Colorectal Cancer.
Kuai XY; Lei ZY; Liu XS; Shao XY
Anticancer Agents Med Chem; 2020; 20(8):941-950. PubMed ID: 32188390
[TBL] [Abstract][Full Text] [Related]
7. Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.
Goos JA; de Cuba EM; Coupé VM; Diosdado B; Delis-Van Diemen PM; Karga C; Beliën JA; Menke-Van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ;
Ann Surg; 2016 Jan; 263(1):138-45. PubMed ID: 25563886
[TBL] [Abstract][Full Text] [Related]
8. Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features.
Sakashita M; Aoyama N; Minami R; Maekawa S; Kuroda K; Shirasaka D; Ichihara T; Kuroda Y; Maeda S; Kasuga M
Eur J Cancer; 2001 Jan; 37(2):204-9. PubMed ID: 11166147
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
[TBL] [Abstract][Full Text] [Related]
10. Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.
Krzeslak A; Wojcik-Krowiranda K; Forma E; Jozwiak P; Romanowicz H; Bienkiewicz A; Brys M
Pathol Oncol Res; 2012 Jul; 18(3):721-8. PubMed ID: 22270867
[TBL] [Abstract][Full Text] [Related]
11. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
12. GLUT1 gene is a potential hypoxic marker in colorectal cancer patients.
Chung FY; Huang MY; Yeh CS; Chang HJ; Cheng TL; Yen LC; Wang JY; Lin SR
BMC Cancer; 2009 Jul; 9():241. PubMed ID: 19619276
[TBL] [Abstract][Full Text] [Related]
13. ¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.
Hong R; Lim SC
World J Gastroenterol; 2012 Jan; 18(2):168-74. PubMed ID: 22253523
[TBL] [Abstract][Full Text] [Related]
14. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis.
Haber RS; Rathan A; Weiser KR; Pritsker A; Itzkowitz SH; Bodian C; Slater G; Weiss A; Burstein DE
Cancer; 1998 Jul; 83(1):34-40. PubMed ID: 9655290
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
[TBL] [Abstract][Full Text] [Related]
16. m
Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
[TBL] [Abstract][Full Text] [Related]
17. LncRNA GAL promotes colorectal cancer liver metastasis through stabilizing GLUT1.
Li B; Kang H; Xiao Y; Du Y; Xiao Y; Song G; Zhang Y; Guo Y; Yang F; He F; Yang S
Oncogene; 2022 Mar; 41(13):1882-1894. PubMed ID: 35149838
[TBL] [Abstract][Full Text] [Related]
18. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
Gao JY; Song BR; Peng JJ; Lu YM
World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
[TBL] [Abstract][Full Text] [Related]
19. Impact of GLUT1 and Ki-67 expression on early‑stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification.
Maki Y; Soh J; Ichimura K; Shien K; Furukawa M; Muraoka T; Tanaka N; Ueno T; Yamamoto H; Asano H; Tsukuda K; Toyooka S; Miyoshi S
Oncol Rep; 2013 Jan; 29(1):133-40. PubMed ID: 23076555
[TBL] [Abstract][Full Text] [Related]
20. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.
Kawamura T; Kusakabe T; Sugino T; Watanabe K; Fukuda T; Nashimoto A; Honma K; Suzuki T
Cancer; 2001 Aug; 92(3):634-41. PubMed ID: 11505409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
